Top compounds associated with response to NELFB


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.031 0.4
mRNA CAY10618 CTRPv2 pan-cancer AAC 0.032 0.4
mRNA BRD-K96431673 CTRPv2 pan-cancer AAC -0.064 0.4
mRNA Dasatinib FIMM pan-cancer AAC -0.16 0.4
mRNA BRD-K03911514 CTRPv2 pan-cancer AAC 0.047 0.4
mRNA SB590885 GDSC1000 pan-cancer AAC 0.029 0.4
mRNA Bleomycin CTRPv2 pan-cancer AAC -0.034 0.4
mRNA PD-0325901 CCLE pan-cancer AAC 0.037 0.4
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.029 0.4
mRNA GDC-0941 gCSI pan-cancer AAC 0.054 0.4
Download CSV